This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Kingfisher (KGF) –Sales in Q2 climbed 1.6% against a 0.4% fall in Q1 with a heightened demand for seasonal products due to the summer weather, when sales in Q1 were hit by winter snow storms across Europe. On track to deliver on targets for 2018, but Castorama was dragging on performance and it had taken steps which should lead to an improvement from the brand in H1 of the year. Closing price 288.09p (Reuters)
Glencore (GLEN) – QHG Oil Ventures, a joint venture between Qatar Investment Authority and Glencore, has valued a 14.2% stake in Rosneft, which it is selling, at €7.4bn. Closing price 298.40p (Reuters)
Marshalls (MSLH) – Sees net debt increase from £24.3m to £48.9m due to purchase of CPM for £41m, H1 revenue climbed 12% to £244m, operating profit climbs 13% to £33.5m from £29.8m previously Interim Dividend Up 18% To 4pp Share. Closing price 420.00p (Reuters)
Kaz Minerals (KAZ) –Announced a interim dividend of 6cents per share, seeing a growing trend for miners to focus on shareholder returns. H1 earnings climbed 20% to $690m versus $505m a year ago, citing higher sales volumes and competitive costs. Operating profit rose to $464m to $291m and copper output grew by 18%. Closing price 549.80p (Reuters)
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| ROYAL BANK OF SCOTLAND | RBS | -1.1% | 1.2% | -1.6% |
| GLAXOSMITHKLINE | GSK | 1.9% | 2.0% | 0.1% |
| HIKMA PHARMACEUTICALS | HIK | 6.0% | 10.4% | 4.2% |
| ADMIRAL | ADM | 3.2% | 5.6% | -0.6% |
| BALFOUR BEATTY | BBY | 0.8% | 3.9% | -0.4% |
| CLS HOLDINGS | CLI | -6.4% | 1.3% | -6.4% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research